February 4, 2012
| Bio-IT World > Resource Center


Resource Center

resource banner

Welcome to Bio-IT World’s Resource Center. This section offers a variety of information ranging from free subscription, complimentary podcasts, interviews and more.

Bookmark this site and check back frequently, as new information is added regularly!

Complimentary Subscriptions Available:

Bio-IT World

Industry news, commentary,
and feature highlights from
Bio-IT World magazine

Biomarker Breakthroughs

All Things Biomarkers

eCliniquaLOGOx125.jpg

Innovative management in Clinical Trials

Weekly Update

Industry news, commentary, and feature
highlights from Bio-IT World magazine

Bio-IT World WRA

New releases from the
Bio-IT World multi-media library

 

 

Complimentary Downloads:

Cloud Computing in Life Sciences R&D Interview Transcript
May 2010

Courtesy of

Insight Pharma Reports

Next-Generation Sequencing Interview Transcript
March 2010

Courtesy of

Insight Pharma Reports

Impact of the 1000 Genomes Project on the Next Wave of Pharmacogenomic Discovery
Interview with M. Eileen Dolan, Ph.D., Professor, Medicine, University of Chicago and Speaker at Next-Generation Sequencing Data Management
Interviewed By Kevin Davies, Editor-in-Chief, Bio-IT World

Download Podcast

The 1000 Genomes Project aims to provide detailed genetic variation data on >1000 genomes from worldwide populations using the next-generation sequencing technologies. Some of the samples utilized for the 1000 Genomes Project are the International Hap-Map samples that are composed of lymphoblastoid cell lines (LCLs) derived from individuals of different world populations. The detailed map of human genetic variation promised by the 1000 Genomes project will allow a more in-depth analysis of the contribution of genetic variation to drug response. Future studies utilizing this new resource can greatly enhance our understanding of the genetic basis of drug response and other complex traits.

Courtesy of

Bio-IT World

Cambridge Healthtech Institute


Life Science 
Webcasts logoCambridge Healthtech Media Group proudly presents Life Science Webcasts -- a series of exclusive one-on-one interviews, presentations and panel discussions conducted by the Bio-IT World editorial team, covering a variety of topics within the life sciences and drug development enterprise.

To view and listen, click on a link below.

2010 Bio-IT World Conference and Expo: "The Future of Personal Genomics"

2009 Bio-IT World Expo genomics panel90x68shim.gifPanel: (From left) Jamie Heywood (co-founder and chairman, PatientsLikeMe), Dietrich Stephan (founder, Ignite Institute), Kari Stefansson (president, deCODE Genetics) and Dan Vorhaus (attorney and founder, Genomics Law Report)
Moderator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Topic: The Future of Personal Genomics
Date: April 2010 / Bio-IT World Expo / Boston
Length: 51:00
View this webcast


Jonathan Rothberg, Genome Analysis Trailblazer

Jonathan Rothberg90x68shim.gif

Guest: Jonathan Rothberg, PhD -- Founder/CEO Ion Torrent Systems; Founder Curagen, 454 Life Sciences, RainDance
Topic: Moore's Law and the Future of Genome Sequencing
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Conference: CHI's Exploring Next-Generation Sequencing – Providence; September 21, 2009
Length: 12:37
View this webcast


John Milton on Oxford Nanopore's Third-Generation Sequencing Technology

John Milton90x68shim.gif

Guest: John Milton PhD, Vice President Research, Oxford Nanopore Technologies, UK
Topic: Oxford Nanopore's Third Generation Sequencing Technologies
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Conference: CHI's Exploring Next-Generation Sequencing – Providence, September 21, 2009
Length: 10:02
View this webcast


2009 Bio-IT World Conference and Expo: Chris Dagdigian

Chris Dagdigian90x68shim.gif

Speaker: Chris Dagdigian, Founding Partner, BioTeam
Topic: The Best, the Worthwhile, and the Most Overhyped Information Technologies for Life Sciences
Conference: Bio-IT World - April 27-29, 2008
Length: 45:07

View this webcast


2009 Bio-IT World Conference and Expo: "The Future of Personal Genomics"

2009 Bio-IT World Expo genomics panel90x68shim.gifPanel: Clifford Reid, CEO, Complete Genomics
Philip Reilly, Third Rock Ventures
Dietrich Stephan, co-founder, Navigenics
Robert Green, Boston University Schools of Medicine and Public Health
John Halamka, CIO, Harvard Medical School
Jorge Conde, CEO, Knome
Moderator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Topic: The Future of Personal Genomic Medicine
Conference: Bio-IT World - April 27-29, 2009
Length: 61:56
View this webcast


Mark Boguski’s Search for Resounding Health

view this webcast90x68shim.gif

Guest: Mark Boguski, M.D., Ph.D., Founder, Resounding Health Incorporated
Topic: Mark Boguski’s Search for Resounding Health
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Length: 17:14

View this webcast


Open-Source Collaborative Models for Personalized Medicine

view this webcast90x68shim.gif

Guest: Jay "Marty" Tenenbaum Ph.D. – Founder and Chairman, CollabRx
Topic: Open-Source Collaborative Models for Personalized Medicine
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Length: 16:40

View this webcast


10 Years at Phase Forward

view this webcast90x68shim.gif

Guest: Paul Bleicher, M.D. – Founder and former Chairman, Phase Forward
Topic: 10 Years at Phase Forward
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Length: 16:44

View this webcast


CHI's Molecular Medicine Tri-Conference 2009 – Preview

view this webcast90x68shim.gif

Guest: Renee Kenney, Director, Scientific Research, Genstruct Inc. 
Topic:
Casual Network Modeling and Best Practices in Drug Discovery
Commentator: Allison Proffitt, Managing Editor, Bio-IT World
Conference: CHI's Molecular Medicine Tri-Conference 2009
Length: 06:11
View this webcast


CHI's Exploring Next-Generation Sequencing

View this Webcast90x68shim.gifGuest: Patrice Milos, Helicos
Topic: Single-Molecule Sequencing and Personalized Medicine
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Conference: CHI's Exploring Next-Generation Sequencing – September 24-25, 2008
Length: 7:54
View this webcast


view this webcast90x68shim.gifGuest: Imad Yassin, Integromics, Spain
Topic: Informatics Solutions for Genomic Analysis and Life Sciences
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Conference: CHI's Exploring Next-Generation Sequencing – September 24-25, 2008
Length: 7:00
View this webcast


view this webcast90x68shim.gifGuest: Michael Cariaso, BioTeam
Topic: Next-Gen Sequencing, Wikis and SNPedia
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Conference: CHI's Exploring Next-Generation Sequencing – September 24-25, 2008
Length: 10:58
View this webcast


View this webcast90x68shim.gifGuest: Laurie Goodman PhD, Public Information Officer, Beijing Genomics Institute, Shenzen, China
Topic: BGI Sequences the First Asian Genome
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Conference: CHI's Exploring Next-Generation Sequencing – September 24-25, 2008
Length: 05:05
View this webcast


2008 Bio-IT World Conference and Expo

View this webcast90x68shim.gifSpeaker: Linda Avey, co-founder, 23andMe, Inc.
Topic: Personalized Genetics: Advancements and Driving Change
Conference: Bio-IT World - April 28-30, 2008
Length: 27:30

View this webcast


view this webcast90x68shim.gifSpeaker: Joshua Boger, Ph.D., President & CEO, Vertex Pharmaceuticals
Topic: Drug Development: Evolving Challenges and Opportunities
Conference: Bio-IT World - April 28-30, 2008
Length: 37:11

View this webcast


View this webcast90x68shim.gifSpeakers: Linda Avey, co-Founder, 23andMe, Inc.
Dietrich Stephan, Ph.D., Co-founder and Chief Science Officer, Navigenics, Inc.
George Church, Ph.D., Professor of Genetics and Director of the Center for Computational Genetics, Harvard Medical School
Jeffrey M. Drazen, M.D., Editor-in-Chief, New England Journal of Medicine; Distinguished Parker B. Francis Professor of Medicine, Harvard Medical School
Fred D. Ledley, M.D., Professor and Chair, Bentley College; Founder and Chairman, My Genome
John Halamka, M.D., M.S., CIO, Harvard Medical School
Moderator: Kevin Davies, Editor-in-Chief, Bio-IT World 
Topic: The Road to Personal Genomics
Conference: Bio-IT World - April 28-30, 2008
Length: 61:02
View this webcast


CHI's Exploring Next-Generation Sequencing

View this webcast90x68shim.gifGuest: Kevin Ulmer, Ph.D., President & CSO, Genome Corp.
Topic: Genome Project
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Conference: CHI's Exploring Next-Generation Sequencing - October 17-18, 2007
Length: 11:10
View this webcast


CHI's Bridging Pharma & IT

View this webcast90x68shim.gifGuest: Jerald S. Schlinder, Dr.P.H., VP Late Stage Clinical Development Statistics, Merck
Topic: Adaptive Clinical Trials
Commentator: Kevin Davies, Ph.D., Editor-in-Chief, Bio-IT World
Conference: CHI's Bridging Pharma & IT - September 30-October 2, 2007
Length: 10:51
View this webcast


CHI's CELLutions Summit

View this webcast90x68shim.gifGuest: Bruce Wentworth, Ph.D., Senior Director, Cardiovascular Research, Genzyme Corp.
Topic: Stem Cell Therapy
Commentator: Malorye Allison, Editor-in-Chief, PharmaWeek, Biomarker Breakthrough
Conference: CHI’s CELLutions Summit - August 20-23, 2007
Length: 09:38
View this webcast


View this webcast90x68shim.gifGuest: Sarah Ferber, Ph.D., Director, Molecular Endocrinology, Sheba Medical Center Institute.
Topic: Cell Therapy
Commentator: Malorye Allison, Editor-in-Chief, PharmaWeek, Biomarker Breakthrough
Conference: CHI’s CELLutions Summit - August 20-23, 2007
Length: 06:10
View this webcast

Courtesy of

Bio-IT World

Cambridge Healthtech Institute



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .